StonvexLoading…
StonvexStonvexStonvexCore line items from UTSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.98M | $10.88M | $15.75M | $14.05M |
Operating Income | $-8.56M | $-7.33M | $-6.81M | $-4.39M |
Net Income | $-7.95M | $-4.37M | $-3.85M | $-5.00M |
EPS (Diluted) | $-0.87 | $-0.48 | $-0.42 | $-0.55 |
Total Assets | $55.91M | $68.20M | $77.48M | $89.23M |
Total Liabilities | $19.41M | $22.97M | $26.10M | $31.77M |
Cash & Equivalents | $33.81M | $43.91M | $49.97M | $54.52M |
Free Cash Flow OCF − CapEx | $-9.24M | $-4.62M | $-4.73M | $7.03M |
Shares Outstanding | 9.19M | 9.16M | 9.11M | 9.07M |